Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Advanced Solid Tumors × lenvatinib × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Hepatocellular 35 Parkinson Disease 4, Autosomal Dominant Lewy Body 26 Carcinoma, Renal Cell 21 Melanoma 10 Endometrial Neoplasms 10 Neoplasms 9 Cholangiocarcinoma 8 Biliary Tract Neoplasms 7 Uterine Cervical Neoplasms 6 Liver Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 5 Triple Negative Breast Neoplasms 4 Thyroid Neoplasms 4 Stomach Neoplasms 4 Recurrence 4 Ovarian Neoplasms 4 Colorectal Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Neuroendocrine Tumors 3 Neoplasm Metastasis 3 Esophageal Squamous Cell Carcinoma 3 Diabetes Mellitus, Insulin-Dependent, 12 3 Breast Neoplasms 3 Adenocarcinoma 3 Vulvar Neoplasms 2 Uveal Melanoma 2 Small Cell Lung Carcinoma 2 Sarcoma 2 Pancreatic Neoplasms 2 Kidney Neoplasms 2

Interventions

Injections 16 Carboplatin 8 pembrolizumab 7 Bevacizumab 7 Leucovorin 6 Fluorouracil 6 Docetaxel 5 Pemetrexed 4 Paclitaxel 4 Oxaliplatin 4 trifluridine tipiracil drug combination 3 atezolizumab 3 Capecitabine 3 tislelizumab 2 spartalizumab 2 sotorasib 2 palbociclib 2 olaparib 2 fludarabine 2 Panitumumab 2 Irinotecan 2 HMPL-013 2 Fulvestrant 2 Etoposide 2 Drug Therapy 2 Cyclophosphamide 2 Cisplatin 2 Cetuximab 2 130-nm albumin-bound paclitaxel 2 zimberelimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡